Plato Investment Management LTD Bristol Myers Squibb CO Transaction History
Plato Investment Management LTD
- $1.48 Trillion
- Q1 2024
A detailed history of Plato Investment Management LTD transactions in Bristol Myers Squibb CO stock. As of the latest transaction made, Plato Investment Management LTD holds 82,913 shares of BMY stock, worth $4.18 Million. This represents 0.46% of its overall portfolio holdings.
Number of Shares
82,913
Previous 4,083
1930.69%
Holding current value
$4.18 Million
Previous $209 Million
3189.79%
% of portfolio
0.46%
Previous 0.26%
Shares
2 transactions
Others Institutions Holding BMY
# of Institutions
2,478Shares Held
1.49BCall Options Held
26MPut Options Held
20M-
Vanguard Group Inc Valley Forge, PA186MShares$9.39 Billion0.2% of portfolio
-
Black Rock Inc. New York, NY163MShares$8.2 Billion0.21% of portfolio
-
State Street Corp Boston, MA91.6MShares$4.62 Billion0.23% of portfolio
-
Jpmorgan Chase & CO New York, NY88.8MShares$4.48 Billion0.44% of portfolio
-
Capital International Investors Los Angeles, CA70.2MShares$3.54 Billion0.79% of portfolio
About BRISTOL MYERS SQUIBB CO
- Ticker BMY
- Exchange NYSE
- Sector Healthcare
- Industry Drug Manufacturers—General
- Shares Outstandng 2,126,160,000
- Market Cap $107B
- Description
- Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, and markets biopharmaceutical products worldwide. It offers products for hematology, oncology, cardiovascular, immunology, fibrotic, neuroscience, and covid-19 diseases. The company's products include Revlimid, an oral immunomodulatory drug for the treatment of multiple my...